6505--sumatriptan

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 has issued a Special Notice announcing a contract award for pharmaceutical procurement. The notice pertains to solicitation 36C77025Q0224 for the procurement of Sumatriptan, a pharmaceutical product classified under PSC 6505 (Drugs and Biologicals) and NAICS code 325412 (Pharmaceutical Preparation Manufacturing). Golden State Medical Supply, Inc. has been awarded the contract valued at $690,539.88, with an effective date of August 8, 2025. The contracting office is located in Leavenworth, Kansas, and Kelly.Mann@va.gov serves as the designated point of contact. This procurement falls under the VA's Network 15 operations and represents a completed competitive acquisition process.

The primary purpose of this Special Notice is to publicly announce the completion and award results of the Sumatriptan pharmaceutical procurement solicitation. The notice establishes a response deadline of September 17, 2025, at 5:00 PM Central Time, with documentation to be archived for 60 days following this response date. No specific set-aside designations were applied to this procurement, indicating it was open to all eligible contractors capable of providing pharmaceutical products. The notice serves as a post-award notification rather than a solicitation for new bids, as the contract has already been awarded and is currently effective. Contractors interested in similar future pharmaceutical supply opportunities with VA Network 15 can reference this award information and maintain contact with the designated contracting office for upcoming procurement activities.